Antiviral Therapeutics Market
Antiviral Therapeutics Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Antiviral Therapeutics Market Size and Growth
The antiviral therapeutics market is experiencing significant growth, driven by increasing viral infection prevalence and innovative drug development. The market size is projected to reach approximately $60 billion by 2027, fueled by advancements in research, expanded treatment options, and rising demand for effective antiviral therapies in various healthcare settings.
Companies Covered
(Covid 19 Impact Covered)
◍ AbbVie Inc.
◍ GSK
◍ Boehringer Ingelheim
◍ Merck
◍ Novartis
◍ Beximco Pharmaceuticals
◍ Pfizer
◍ Roche
◍ Bristol-Myers Squibb Company
◍ Johnson & Johnson
◍ Sanofi
The antiviral therapeutics market features key players like AbbVie, GSK, Merck, and Pfizer, focusing on innovative drug development. These companies enhance market growth through research, strategic collaborations, and expanding product pipelines. Notable revenues include AbbVie ($60 billion), Pfizer ($81 billion), and Merck ($59 billion), reflecting strong market presence.
Request Sample Report
Market Segmentation
By Application
◍ Hospitals
◍ Clinics
◍ Ambulatory Surgical Centers
◍ Pharmacies
◍ Others
By Product
◍ Herpes Antiviral Drugs
◍ Hepatitis Antiviral Drugs
◍ HIV Antiviral Drugs
◍ Influenza Antiviral Drugs
◍ Others
Request Sample Report
$ 82.59 Billion
Request Sample Report
